Our key novel finding from in vitro and in vivo studies is that MET inhibition by SGX523 reduced proliferation and tumor growth in the H1975L858R/T790M cells and inhibited indices of stromal deposition in H1975L858R cells. This evidence concerns the gene MET and neoplasm.